Corebridge Financial’s AnaptysBio ANAB Stock Holding History

Corebridge Financial’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,590	Closed	-$197K	–	169
2025 Q1	$197K	Sell	10,590 -157	-1%	-$2.62K	﹤0.01%	2094
2024 Q4	$142K	Buy	10,747 +285	+3%	+$6.9K	﹤0.01%	2367
2024 Q3	$350K	Sell	10,462 -64	-0.6%	-$2.19K	﹤0.01%	1914
2024 Q2	$264K	Buy	+10,526	New	+$245K	﹤0.01%	2032

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Corebridge Financial's ANAB Position: Q2 2025 in Review

Corebridge Financial sold out of AnaptysBio (ANAB) in Q2 2025, closing a stake of 10,590 shares — an estimated $197K sold.

Corebridge Financial first reported a position in ANAB in Q2 2024 and held it in 4 quarters. The position peaked at $350K in Q3 2024. 147 funds tracked by Wall St. Rank hold ANAB as of Q2 2025.

Corebridge Financial reported no remaining AnaptysBio position as of Q2 2025 after selling out during the quarter.
Corebridge Financial sold 10,590 AnaptysBio shares in Q2 2025, an estimated $197K.
Corebridge Financial first reported a position in AnaptysBio in Q2 2024 and held it in 4 quarters.
Corebridge Financial's AnaptysBio position peaked at $350K in Q3 2024.
147 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.